NDC 59584-138

Candin

Candida Albicans Skin Test Antigen

Candin is a Intradermal Injection, Solution in the Standardized Allergenic category. It is labeled and distributed by Nielsen Biosciences, Inc.. The primary component is Candida Albicans.

Product ID59584-138_4254e4c8-4a44-4766-8caf-61c65dc3267c
NDC59584-138
Product TypeStandardized Allergenic
Proprietary NameCandin
Generic NameCandida Albicans Skin Test Antigen
Dosage FormInjection, Solution
Route of AdministrationINTRADERMAL
Marketing Start Date1995-12-01
Marketing CategoryBLA / BLA
Application NumberBLA103257
Labeler NameNielsen BioSciences, Inc.
Substance NameCANDIDA ALBICANS
Active Ingredient Strength1 U/.1mL
Pharm ClassesNon-Standardized Fungal Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Fungal Proteins [CS],Allergens [CS]
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 59584-138-01

1 mL in 1 VIAL, MULTI-DOSE (59584-138-01)
Marketing Start Date1995-12-01
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 59584-138-01 [59584013801]

Candin INJECTION, SOLUTION
Marketing CategoryBLA
Application NumberBLA103257
Product TypeSTANDARDIZED ALLERGENIC
Billing UnitML
Marketing Start Date1995-12-01

Drug Details

Active Ingredients

IngredientStrength
CANDIDA ALBICANS1 U/.1mL

Pharmacological Class

  • Non-Standardized Fungal Allergenic Extract [EPC]
  • Increased Histamine Release [PE]
  • Cell-mediated Immunity [PE]
  • Increased IgG Production [PE]
  • Fungal Proteins [CS]
  • Allergens [CS]

Trademark Results [Candin]

Mark Image

Registration | Serial
Company
Trademark
Application Date
CANDIN
CANDIN
74351614 1970269 Live/Registered
NIELSEN BIOSCIENCES, INC.
1993-01-25

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.